Five sera from patients with DM immunoprecipitated the biotinylated recombinant Mi-2β by IPP [4], and these had been confirmed to have anti-Mi-2 antibodies by IPP-WB by using anti-Mi-2α monoclonal antibody [4]. This evidence concerns the gene IPP and dermatomyositis.